The system was designed by researchers from the National University of La Plata (UNLP) and works for continuous monitoring of the patient's glucose, subsequently this data is sent to the patient's mobile phone and a web server.
Researchers from the UNLP Faculty of Engineering conducted a remote monitoring test in intensive care units (ICU). The ULP authorities reported that the telemedicine system project showed very encouraging results, completing more than a thousand hours of monitoring in ICU patients, which allowed them to be stabilized metabolically.
The system consists of a continuous glucose monitor (CGM), a smartphone and a web server. Measurements taken by the CGM are sent via the mobile phone's WiFi connection. This data is then uploaded over a 4G mobile network or WiFi to web servers, allowing patients and specialists to access this data from mobile devices or computers.
“GMOs have recently been approved for use in hospitalized patients in the context of the pandemic, so the system developed by UNLP engineers is one of the first experiences worldwide in remote monitoring of critical patients,” the university said in a statement.
Fabricio Garelli, project manager, explained that the first stage of development is surpassed, as is the validation of the monitoring platform “which has become a relevant care tool for the treatment of patients with diabetes or hyperglycemia in COVID-19 ICU”.
The platform was used in intensive care units of the Italian Hospital of Buenos Aires and Garrahan Hospital. “In all cases the use of the platform allowed metabolic stabilization of treated patients. It also made important conclusions about the effects of SARS-CoV-2 virus on patients, and the adoption of a new protocol for the treatment of hyperglycemia in critical patients,” Garelli explained.
The platform is currently available to all hospitals looking to use it. To learn more, go to the following link: http://www.insumate.com.ar/
